Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors.
Hamblin, J.N., Angell, T.D., Ballantine, S.P., Cook, C.M., Cooper, A.W., Dawson, J., Delves, C.J., Jones, P.S., Lindvall, M., Lucas, F.S., Mitchell, C.J., Neu, M.Y., Ranshaw, L.E., Solanke, Y.E., Somers, D.O., Wiseman, J.O.(2008) Bioorg Med Chem Lett 18: 4237-4241
- PubMed: 18539455 
- DOI: https://doi.org/10.1016/j.bmcl.2008.05.052
- Primary Citation of Related Structures:  
3D3P - PubMed Abstract: 
Optimisation of a high-throughput screening hit resulted in the discovery of 4-(substituted amino)-1-alkyl-pyrazolo[3,4-b]pyridine-5-carboxamides as potent and selective inhibitors of Phosphodiesterase 4 (PDE4). Herein, we describe early SAR studies around this novel template highlighting preferred substituents and rationalization of SAR through X-ray crystal structures of analogues bound to the PDE4 active site ...